About: Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1999 (uk) im Juli 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1999 (ast) scientific article published on 01 July 1999 (en)
publication date	wds:Q78245024-53CB56C3-E3A4-43DA-886E-C12686307391
publication date	1999-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q78245024-ACF40DFF-2809-427C-ADFE-9431A59C7325
language of work or name	English
cites work	wds:Q78245024-05E54BB5-0BBD-45B3-8484-D22B8CCBA1CD wds:Q78245024-1106CABF-6918-4156-AFA5-1D2EBD92A8E5 wds:Q78245024-3C3D0EEB-313C-4877-A47B-DB0363EFDDCA wds:Q78245024-49CBBF1F-00E0-4388-AE06-6CAF8D88EB76 wds:Q78245024-68F8C9C8-3802-4538-9177-E82A4B9DF9A1 wds:Q78245024-6BE35C27-B653-4C91-B46C-5B0C69F1679A wds:Q78245024-7895B35F-6130-41A3-9704-B44C54553630
cites work	Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study Systemic side effects of topical beta-adrenergic blockers Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma.
author name string	wds:Q78245024-3CA54CB2-5DC3-4A2F-8151-EC0CFC0B07B4 wds:Q78245024-599392A3-947B-4E07-9A52-EC19F7074FCA wds:Q78245024-C1735B1E-6A7F-4F9F-BAD3-64EE32676DFD wds:Q78245024-C585A5B8-D04C-477D-8EC0-74C9A4AAC8A1 wds:Q78245024-E5FCD37A-7BD6-4767-A2E1-599720B2A027
author name string	W C Stewart A G Konstas S Gandi A C Hudgins A C Maltezos
rdfs:label	Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (en) Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (nl)
skos:prefLabel	Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (en) Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (nl)
name	Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (en) Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (nl)
title	wds:Q78245024-87DCC06C-BBC0-441F-B1E0-0619F76140C3
title	Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (en)
page(s)	wds:Q78245024-281F3253-6220-4B4F-A490-9AE7E67DEA63
page(s)	15-20
instance of	wds:Q78245024-90ACBA14-003D-41F1-8DE9-1DBA80CF8A47
instance of	scholarly article
main subject	wds:Q78245024-31ADDB5D-9B1C-4A7F-B50D-B83EF6B62BBF wds:Q78245024-856739B5-0E86-4A14-B479-2EE07F5CD4A9 wds:Q78245024-E8A8D63A-1E17-45B4-9D71-A10E9D2BA32A
main subject	latanoprost open-angle glaucoma timolol maleate
PubMed ID	wds:Q78245024-949D4466-64C2-489C-B35E-655CDE623EC4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10482089
PubMed ID	10482089
published in	wds:Q78245024-48C07015-8B7F-452E-9D1E-55142C22FC5D
published in	American Journal of Ophthalmology
issue	wds:Q78245024-924EFF74-4238-4548-9B3D-3ED817244CE5
volume	wds:Q78245024-A54C71D5-105C-4422-8EBF-1548925F0B8E
issue	1
volume	128
DOI	wds:Q78245024-B62C9795-37C9-4213-8260-4EB077715780
DOI	http://dx.doi.org/10.1016/S0002-9394(99)00073-2
DOI	10.1016/S0002-9394(99)00073-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q78245024
is cites work of	Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol Latanoprost : an update of its use in glaucoma and ocular hypertension 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course. Current status of prostaglandin therapy: latanoprost and unoprostone Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany Mechanism - based translational pharmacokinetic - pharmacodynamic model to predict intraocular pressure lowering effect of drugs in patients with glaucoma or ocular hypertension Brimonidine and latanoprost as adjunctive therapy Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy A model-based meta-analysis of the effect of latanoprost chronotherapy on the circadian intraocular pressure of patients with glaucoma or ocular hypertension Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma 24-h Efficacy of Glaucoma Treatment Options A biodegradable ocular implant for long-term suppression of intraocular pressure. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial Optimal sampling scheme for estimation of intraocular pressure diurnal curves in glaucoma trials

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software